Roclub Secures $11.7M, Targets U.S. Medtech Staffing Crisis with AI Teleoperations
October 22, 2025, 9:38 pm
Roclub, a pioneering medtech teleoperation platform, has raised $11.7 million in Series A funding. This significant investment fuels its ambitious expansion into the crucial U.S. market. The company directly addresses a severe national shortage of medical technologists. Its cloud- and AI-based platform allows remote control of vital imaging equipment like MRI and CT scanners. This innovative approach optimizes device utilization and ensures business continuity. Roclub will also launch a technologist marketplace. This platform connects healthcare providers with qualified remote operators. It promises to transform patient access, reduce wait times, and empower technologists with flexible work options. Roclub aims to set the global standard for secure, intelligent remote medical device access. The funding will accelerate AI development and double the workforce in 2026. This strategic move promises to reshape healthcare delivery.
The medical technology landscape faces unprecedented challenges. Staffing shortages plague healthcare systems worldwide. This critical issue leaves advanced equipment underutilized. Patient access to vital diagnostics suffers. Roclub, a groundbreaking teleoperation platform, offers a powerful solution. The company recently announced an $11.7 million Series A funding round. This substantial investment will accelerate its expansion into the United States. It will also advance its AI-driven platform development.
Roclub’s core mission is clear: revolutionize how healthcare providers operate complex medical equipment. The platform enables secure, remote access and control of devices. Initially, it focuses on MRI and CT scanners. Expansion to other modalities is planned. This vendor-agnostic system integrates with scanners from any manufacturer. It allows technologists to operate multiple machines across different sites. This boosts efficiency. It improves equipment utilization significantly. It dramatically reduces costly downtime.
The technology behind Roclub is robust. It features a cloud- and AI-based architecture. A compact, smartphone-sized device, the Roclub connector, forms the backbone. This connector attaches to any monitored medtech device. It serves as a front-end interface. It allows real-time remote access. It provides seamless control. Integrated video and audio communication connect remote operators, on-site staff, and patients. This enhances collaboration. It ensures precise, supervised operations.
Medical technologist shortages are acute. The U.S. healthcare system feels this pressure profoundly. Roclub directly confronts this crisis. By easing staffing constraints, it broadens patient access. High-quality radiological services become more consistent. Advanced diagnostics reach more people. The platform also offers hybrid-work flexibility for technologists. This attracts new talent. It retains experienced professionals. It reduces patient wait times. It improves overall care outcomes.
The company's origins highlight this pressing need. Roclub was founded in 2022 by Dr. Matthias Issing and André Glardon. They previously managed a large network of diagnostic centers in Europe. They witnessed firsthand the impact of technologist shortages. Equipment often sat idle. Patients faced delays. This direct experience fueled their innovative vision. Roclub now operates successfully in 11 countries across Europe. It serves major hospitals and outpatient imaging providers.
Roclub’s expansion into the U.S. market is strategic. The United States presents unique challenges. Regional disparities in healthcare staffing are common. Reimbursement-driven efficiency pressures are intense. Roclub's solution aligns perfectly with these demands. It promises to alleviate critical staffing gaps. It offers a scalable, efficient model for equipment operation.
A key development is Roclub's planned technologist marketplace. This platform will launch in late 2025. It will connect hospitals and clinics with certified technologists. These professionals can remotely operate connected imaging and diagnostic equipment. This initiative aims to address staffing shortages in rural and underserved regions. It simultaneously provides flexible, location-independent work opportunities for technologists. This creates a win-win scenario for both providers and professionals.
The recent funding round validates Roclub's potential. Smedvig Ventures and YZR Capital co-led the Series A round. Existing investor Speedinvest also participated. Angel investors contributed. This capital will accelerate AI-driven development. It will further enhance the teleoperation platform. It supports the marketplace launch. It enables significant growth.
Roclub plans aggressive expansion. The company will double its headcount in 2026. It will strengthen its sales and customer success functions. This growth supports its entry into the demanding U.S. market. It underpins its global ambitions. Roclub aims to establish itself as the worldwide benchmark for teleoperation in medtech.
The vision is expansive. Roclub unifies medtech, robotics, AI, and ultra-low-latency connectivity. This powerful combination empowers technologists and clinicians. They can perform complex procedures with precision. Collaboration across borders becomes seamless. Access to expert care transforms into a truly global capability. Roclub is not just a technology provider. It is a catalyst for change. It redefines healthcare delivery. It promises better patient outcomes everywhere.
The medical technology landscape faces unprecedented challenges. Staffing shortages plague healthcare systems worldwide. This critical issue leaves advanced equipment underutilized. Patient access to vital diagnostics suffers. Roclub, a groundbreaking teleoperation platform, offers a powerful solution. The company recently announced an $11.7 million Series A funding round. This substantial investment will accelerate its expansion into the United States. It will also advance its AI-driven platform development.
Roclub’s core mission is clear: revolutionize how healthcare providers operate complex medical equipment. The platform enables secure, remote access and control of devices. Initially, it focuses on MRI and CT scanners. Expansion to other modalities is planned. This vendor-agnostic system integrates with scanners from any manufacturer. It allows technologists to operate multiple machines across different sites. This boosts efficiency. It improves equipment utilization significantly. It dramatically reduces costly downtime.
The technology behind Roclub is robust. It features a cloud- and AI-based architecture. A compact, smartphone-sized device, the Roclub connector, forms the backbone. This connector attaches to any monitored medtech device. It serves as a front-end interface. It allows real-time remote access. It provides seamless control. Integrated video and audio communication connect remote operators, on-site staff, and patients. This enhances collaboration. It ensures precise, supervised operations.
Medical technologist shortages are acute. The U.S. healthcare system feels this pressure profoundly. Roclub directly confronts this crisis. By easing staffing constraints, it broadens patient access. High-quality radiological services become more consistent. Advanced diagnostics reach more people. The platform also offers hybrid-work flexibility for technologists. This attracts new talent. It retains experienced professionals. It reduces patient wait times. It improves overall care outcomes.
The company's origins highlight this pressing need. Roclub was founded in 2022 by Dr. Matthias Issing and André Glardon. They previously managed a large network of diagnostic centers in Europe. They witnessed firsthand the impact of technologist shortages. Equipment often sat idle. Patients faced delays. This direct experience fueled their innovative vision. Roclub now operates successfully in 11 countries across Europe. It serves major hospitals and outpatient imaging providers.
Roclub’s expansion into the U.S. market is strategic. The United States presents unique challenges. Regional disparities in healthcare staffing are common. Reimbursement-driven efficiency pressures are intense. Roclub's solution aligns perfectly with these demands. It promises to alleviate critical staffing gaps. It offers a scalable, efficient model for equipment operation.
A key development is Roclub's planned technologist marketplace. This platform will launch in late 2025. It will connect hospitals and clinics with certified technologists. These professionals can remotely operate connected imaging and diagnostic equipment. This initiative aims to address staffing shortages in rural and underserved regions. It simultaneously provides flexible, location-independent work opportunities for technologists. This creates a win-win scenario for both providers and professionals.
The recent funding round validates Roclub's potential. Smedvig Ventures and YZR Capital co-led the Series A round. Existing investor Speedinvest also participated. Angel investors contributed. This capital will accelerate AI-driven development. It will further enhance the teleoperation platform. It supports the marketplace launch. It enables significant growth.
Roclub plans aggressive expansion. The company will double its headcount in 2026. It will strengthen its sales and customer success functions. This growth supports its entry into the demanding U.S. market. It underpins its global ambitions. Roclub aims to establish itself as the worldwide benchmark for teleoperation in medtech.
The vision is expansive. Roclub unifies medtech, robotics, AI, and ultra-low-latency connectivity. This powerful combination empowers technologists and clinicians. They can perform complex procedures with precision. Collaboration across borders becomes seamless. Access to expert care transforms into a truly global capability. Roclub is not just a technology provider. It is a catalyst for change. It redefines healthcare delivery. It promises better patient outcomes everywhere.